Translate this page into:
Special note: Dyslipidemia in Women
*Corresponding author: H. K. Chopra, Department of Cardiology, Medanta Moolchand Heart Institute, New Delhi, India. drhkchopra@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Chopra HK. Special note: Dyslipidemia in Women. Indian J Cardiovasc Dis Women. 2025;10:250-1. doi: 10.25259/IJCDW_87_2025
It is a great pleasure and honor indeed for me in writing the editorial for the need based state of art Special Issue on “Dyslipidemia in Women” in the forthcoming Indian Journal of Cardiovascular Disease in Women (IJCDW), first of its kind, from India to the world with brainstorming, mindboggling, and scintillating, thought provoking contents on every possible aspect.
Cardiovascular disease remains the leading cause of morbidity and mortality among women worldwide, yet for decades, the perception of heart disease as a “man’s illness” has delayed progress in understanding its unique manifestation in women. Among the multitude of risk factors, dyslipidemia occupies a pivotal position, not only as a modifiable determinant of atherosclerotic cardiovascular disease but also as a window into the intricate interplay of hormonal, genetic, and metabolic influences that define women’s cardiovascular health across their lifespan.
This special issue “Dyslipidemia in Women” comes at a crucial juncture when gender-specific medicine is gaining deserved recognition. It brings together the latest evidence, expert perspectives, and practical clinical guidance to bridge the gap between science and practice. The authors have meticulously highlighted how lipid disorders in women differ in their epidemiology, pathophysiology, clinical expression, and response to therapy compared to men. From puberty to menopause and beyond, the text explores how hormonal transitions, pregnancy, polycystic ovary syndrome, diabetes, and menopause modulate lipid metabolism and cardiovascular risk.
Equally commendable is the Special Issue on “Dyslipidemia in Women” emphasis on personalized and preventive strategies, encompassing lifestyle interventions, pharmacotherapy, and emerging lipid-lowering agents. By contextualizing research data within women-centric frameworks, it guides clinicians toward evidence-based and compassionate care reducing residual risk and improving outcomes. Women are unique phenotypically, genotypically, metabolically, biochemically, psychologically, emotionally, and neuroharmonically. At the level of mitochondria, protonically, neutronically, electronically, bosonically, and even at quantum soup, therefore, their responses and outcomes are different in the lipid management.
The Journal comprises 13 articles in all spectrums in dyslipidemia management in women by women centric approach. The articles are well outlined, structured, well written, and referenced. The writing style of every article is vivid, concise, and practical. There are excellent graphics, tables, figures, and algorithms that present the relevant information. The printing and binding is of excellent quality.
I sincerely congratulate the Chief Editor Dr. Jyotsna Maddury and Executive Editor Dr. Sarita Rao and contributors for their scholarly dedication and vision in compiling this outstanding work. It will serve as an invaluable resource for cardiologists, endocrinologists, physicians, researchers, and all those committed to advancing cardiovascular health in women.
This special issue is not merely an academic contribution; it is a call to action for integrating gender equity in cardiovascular prevention and treatment, ensuring that women across all ages benefit from the full spectrum of modern lipid science.
“The good physician treats the disease; the great physician treats the patient who has the disease and a super great physician prevent the disease by enhancing awareness on Dyslipidemia in Women by women centric approach”.